125
Participants
Start Date
January 31, 2014
Primary Completion Date
February 28, 2018
Study Completion Date
February 13, 2018
LEO 80185 gel
St. Luke's Roosevelt Hospital, Forest Hills
Charite Berlin, Berlin
Clinical Partners, Johnston
Cabinet Medical, Martigues
"Spitalul Clinic Colentina", Bucharest
Katholisches Kinderkrankenhaus, Hamburg
CHI de Cornouaille, Quimper
Dermatology and Laser Center of Charleston, PA, Charleston
Clinical Research Center, Morsani Center for Advanced Healthcare, Tampa
Indiana University, Indianapolis
Uniklinik Bonn, Bonn
Uniklinik Frankfurt, Frankfurt am Main
Skin Specialists, PC, Omaha
Clinical Trials of Texas, Inc., San Antonio
Rady's Children Hospital, San Diego
Spitalul Clinic Municipal de Urgenta Timisoara, Timișoara
Spitalul Clinic Judetean de Urgenta Cluj-Napoca, Cluj-Napoca
Policlinica de Diagnostic Rapid S.A. Clinic, Brasov
Iasiprest SRL Dermato-Venerology, Iași
Cabinet Medical Individual Tatu G. Alin Laurentiu, Galati
Spitalul Clinic Judetean Mures, Târgu Mureş
Winnipeg Clinic, Winnipeg
Adult, Pediatric and Laser Derma, St. John's
Lynderm Research Inc., Markham
Skin Centre for Dermatology, Peterborough
CHU de Nice, Nice
Endo - Med. Centrum Medyczne Clinic, Karczew
NZOZ Med.-Laser Clinic, Lublin
Specjalistyczny Ofrodek Leczniczo Clinic, Ostróda
Medycyna Kliniczna Clinic, Warsaw
Derm Medica Sp.zo.o. Clinic, Wroclaw
Manchester Royal Infirmary, Manchester
Monklands Hospital, Airdrie
Whipps Cross University Hospital, Leytonstone
St. Woolos Hospital, Stow Hill, Newport
Lead Sponsor
LEO Pharma
INDUSTRY